Insider · CIK 0001360376

Lasowski Juergen

Reports to the SEC for 2 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001360376

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-10-01	ONYX PHARMACEUTICALS INCU Disposition from Tender	EVP, Corp. Dev & Strategy	UDisposition from Tender	−1,833 sh	$125.00	−$229K	30,250
2013-10-01	ONYX PHARMACEUTICALS INCD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−30.3K sh	$125.00	−$3.78M	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−11.2K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−72.8K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−2,625 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−3,452 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−38.5K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−2,500 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−37.5K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−925 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−37.6K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−2,653 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−43.2K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−20.1K sh	—	—	0
2013-07-01	ONYX PHARMACEUTICALS INCM Exercise/Conversion	EVP, Corp. Dev & Strategy	MExercise/Conversion	+25.4K sh	$28.55	+$724K	57,458
2013-07-01	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−25.4K sh	$132.63	−$3.37M	32,083
2013-07-01	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Corp. Dev & Strategy	MExercise/Conversion	−25.4K sh	—	—	2,625
2013-05-14	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−2,988 sh	$96.38	−$288K	33,277
2013-05-14	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−1,194 sh	$97.13	−$116K	32,083
2013-04-01	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−776 sh	$86.14	−$66.8K	38,140
2013-04-01	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−711 sh	$86.13	−$61.2K	37,429
2013-04-01	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−1,164 sh	$86.14	−$100K	36,265
2013-03-28	ONYX PHARMACEUTICALS INCA Award	EVP, Corp. Dev & Strategy	AAward	+7,100 sh	—	—	38,916
2013-03-28	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP, Corp. Dev & Strategy	AAward	+20.1K sh	—	—	20,100
2012-10-05	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−5,902 sh	$90.00	−$531K	31,816
2012-07-25	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−5,348 sh	$73.97	−$396K	48,968
2012-07-02	ONYX PHARMACEUTICALS INCM Exercise/Conversion	EVP, Corp. Dev & Strategy	MExercise/Conversion	+14K sh	$28.55	+$400K	71,942
2012-07-02	ONYX PHARMACEUTICALS INCD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−14K sh	$67.24	−$941K	57,942
2012-07-02	ONYX PHARMACEUTICALS INCD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−2,326 sh	$66.62	−$155K	55,616
2012-07-02	ONYX PHARMACEUTICALS INCD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−1,300 sh	$67.73	−$88K	54,316
2012-07-02	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Corp. Dev & Strategy	MExercise/Conversion	−14K sh	—	—	25,375
2012-04-02	ONYX PHARMACEUTICALS INCD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−757 sh	$36.58	−$27.7K	59,393
2012-04-02	ONYX PHARMACEUTICALS INCD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−694 sh	$36.58	−$25.4K	58,699
2012-04-02	ONYX PHARMACEUTICALS INCD Disposition to Issuer	EVP, Corp. Dev & Strategy	DDisposition to Issuer	−757 sh	$36.58	−$27.7K	57,942
2012-03-30	ONYX PHARMACEUTICALS INCA Award	EVP, Corp. Dev & Strategy	AAward	+9,000 sh	—	—	43,000
2012-03-30	ONYX PHARMACEUTICALS INCA Award	EVP, Corp. Dev & Strategy	AAward	+17.2K sh	—	—	60,150
2012-03-30	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP, Corp. Dev & Strategy	AAward	+45.9K sh	—	—	45,900
2012-01-03	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−1,232 sh	$42.64	−$52.5K	34,000
2011-09-01	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−1,006 sh	$34.14	−$34.3K	35,232
2011-08-01	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−1,665 sh	$33.27	−$55.4K	36,238
2011-05-20	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−591 sh	$43.02	−$25.4K	37,241
2011-05-20	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−3 sh	$43.53	−$130.59	37,238
2011-05-06	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−3,783 sh	$40.00	−$151K	37,832
2011-04-01	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−1,478 sh	$35.02	−$51.8K	41,615
2011-03-31	ONYX PHARMACEUTICALS INCA Award	EVP, Corp. Dev & Strategy	AAward	+5,500 sh	—	—	20,593
2011-03-31	ONYX PHARMACEUTICALS INCA Award	EVP, Corp. Dev & Strategy	AAward	+22.5K sh	—	—	43,093
2011-03-31	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP, Corp. Dev & Strategy	AAward	+38.5K sh	—	—	38,500
2011-03-31	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP, Corp. Dev & Strategy	AAward	+40K sh	—	—	40,000
2010-05-20	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−592 sh	$24.06	−$14.2K	13,869
2010-05-20	ONYX PHARMACEUTICALS INCS Sale	EVP, Corp. Dev & Strategy	SSale	−8 sh	$24.40	−$195.2	13,861

Recent filings

Accepted (ET)
Oct 34
ONYX PHARMACEUTICALS INC0001181431-13-052505
SEC(opens sec.gov)
Jul 24
ONYX PHARMACEUTICALS INC0001179110-13-011357
SEC(opens sec.gov)
May 164
Lasowski Juergen0001179110-13-008589
SEC(opens sec.gov)
Apr 34
Lasowski Juergen0001179110-13-006443
SEC(opens sec.gov)

Companies

Address

C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL ST., 12TH FLOOR

EMERYVILLE, CA, 94608